These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36568126)

  • 1. A New Non-Linear Conjugate Gradient Algorithm for Destructive Cure Rate Model and a Simulation Study: Illustration with Negative Binomial Competing Risks.
    Pal S; Roy S
    Commun Stat Simul Comput; 2022; 51(11):6866-6880. PubMed ID: 36568126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simplified stochastic EM algorithm for cure rate model with negative binomial competing risks: An application to breast cancer data.
    Pal S
    Stat Med; 2021 Dec; 40(28):6387-6409. PubMed ID: 34783093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the parameter estimation of Box-Cox transformation cure model.
    Pal S; Roy S
    Stat Med; 2023 Jul; 42(15):2600-2618. PubMed ID: 37019798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the estimation of interval censored destructive negative binomial cure model.
    Treszoks J; Pal S
    Stat Med; 2023 Dec; 42(28):5113-5134. PubMed ID: 37706586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stochastic EM algorithm for generalized exponential cure rate model and an empirical study.
    Davies K; Pal S; Siddiqua JA
    J Appl Stat; 2021; 48(12):2112-2135. PubMed ID: 35706615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cure rate models for heterogeneous competing causes.
    Brandão M; Leão J; Gallardo DI; Bourguignon M
    Stat Methods Med Res; 2023 Sep; 32(9):1823-1841. PubMed ID: 37489264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expectation maximization-based likelihood inference for flexible cure rate models with Weibull lifetimes.
    Balakrishnan N; Pal S
    Stat Methods Med Res; 2016 Aug; 25(4):1535-63. PubMed ID: 23740876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expectation Maximization Algorithm for Box-Cox Transformation Cure Rate Model and Assessment of Model Misspecification Under Weibull Lifetimes.
    Pal S; Balakrishnan N
    IEEE J Biomed Health Inform; 2018 May; 22(3):926-934. PubMed ID: 28534799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Likelihood inference for COM-Poisson cure rate model with interval-censored data and Weibull lifetimes.
    Pal S; Balakrishnan N
    Stat Methods Med Res; 2017 Oct; 26(5):2093-2113. PubMed ID: 28656795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The destructive negative binomial cure rate model with a latent activation scheme.
    Cancho VG; Bandyopadhyay D; Louzada F; Yiqi B
    Stat Methodol; 2013 Jul; 13():48-68. PubMed ID: 23585760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penalized likelihood estimation of a mixture cure Cox model with partly interval censoring-An application to thin melanoma.
    Webb A; Ma J; Lô SN
    Stat Med; 2022 Jul; 41(17):3260-3280. PubMed ID: 35474515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inference of progressively type-II censored competing risks data from Chen distribution with an application.
    Ahmed EA; Ali Alhussain Z; Salah MM; Haj Ahmed H; Eliwa MS
    J Appl Stat; 2020; 47(13-15):2492-2524. PubMed ID: 35707419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vertical modeling: analysis of competing risks data with a cure fraction.
    Nicolaie MA; Taylor JMG; Legrand C
    Lifetime Data Anal; 2019 Jan; 25(1):1-25. PubMed ID: 29388073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation method of the semiparametric mixture cure gamma frailty model.
    Peng Y; Zhang J
    Stat Med; 2008 Nov; 27(25):5177-94. PubMed ID: 18613271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EM algorithms for fitting multistate cure models.
    Beesley LJ; Taylor JMG
    Biostatistics; 2019 Jul; 20(3):416-432. PubMed ID: 29584820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incorporation of frailties into a cure rate regression model and its diagnostics and application to melanoma data.
    Leão J; Leiva V; Saulo H; Tomazella V
    Stat Med; 2018 Dec; 37(29):4421-4440. PubMed ID: 30109718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the use of the modified power series family of distributions in a cure rate model context.
    Gallardo DI; Gómez YM; Gómez HW; de Castro M
    Stat Methods Med Res; 2020 Jul; 29(7):1831-1845. PubMed ID: 31559906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid genetic and variational expectation-maximization algorithm for gaussian-mixture-model-based brain MR image segmentation.
    Tian G; Xia Y; Zhang Y; Feng D
    IEEE Trans Inf Technol Biomed; 2011 May; 15(3):373-80. PubMed ID: 21233052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyzing semi-competing risks data with missing cause of informative terminal event.
    Zhou R; Zhu H; Bondy M; Ning J
    Stat Med; 2017 Feb; 36(5):738-753. PubMed ID: 27813148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.